Uploaded April 2026 | Updated November 2026, 2 days ago
We are excited to bring you a new episode of #ExpertTalk by EverythingALS.
In this session, we are joined by Dr. Jack Humphrey, PhD, Assistant Professor in the Department of Neuroscience at the Icahn School of Medicine at Mount Sinai, for an in-depth discussion on how large-scale patient data is transforming our understanding of ALS.
Dr. Humphrey explores how integrating genetics, functional genomics, and real-world patient data is helping researchers uncover the biological mechanisms that drive ALS and related neurodegenerative diseases. He explains how advances in computational biology and access to large, collaborative datasets are allowing scientists to move beyond isolated findings and begin identifying broader patterns across diverse patient populations.
Throughout the discussion, Dr. Humphrey highlights the importance of global collaboration between researchers, clinicians, and the ALS community. He shares how post-mortem tissue analysis, genomic sequencing, and AI-driven approaches are being used together to better understand disease origins, progression, and potential therapeutic targets.
In this talk, we cover:
• How large-scale patient datasets are advancing ALS research
• The role of genetics and molecular pathways in disease development
• Why collaboration across institutions and countries is critical
• How AI and computational tools are accelerating discovery
• The challenges of working with complex, real-world data
• Emerging insights into ALS and related neurodegenerative diseases
This conversation underscores the growing role of data-driven science in ALS research. By combining patient experience with cutting-edge technology, researchers are building a more complete picture of the disease and opening new pathways toward meaningful treatments.
📲 Download the EverythingALS App
• Google Play: bit.ly/4nXqIYy
• App Store: bit.ly/42tPBmh
Follow EverythingALS:
► Website: everythingals.org
► X: https://x.com/everything_als
► LinkedIn: linkedin.com/everythingals
► Facebook: facebook.com/EverythingALS
► Subscribe for more Expert Talks: youtube.com/c/everythingals
#ExpertTalk #EverythingALS #ALSResearch #ALSCommunity #NeurodegenerativeDisease #ALSScience #ALSData #BigData #ALSAdvocacy #ALSUpdates #ALSExperts #CollaborativeScience
🔔 If you are passionate about advancing ALS research and understanding, like, subscribe, and turn on notifications.
Sharing this episode helps expand awareness and keeps important scientific conversations moving forward.
We are excited to bring you a new episode of #ExpertTalk by EverythingALS.
In this session, we are joined by Dr. Jack Humphrey, PhD, Assistant Professor in the Department of Neuroscience at the Icahn School of Medicine at Mount Sinai, for an in-depth discussion on how large-scale patient data is transforming our understanding of ALS.
Dr. Humphrey explores how integrating genetics, functional genomics, and real-world patient data is helping researchers uncover the biological mechanisms that drive ALS and related neurodegenerative diseases. He explains how advances in computational biology and access to large, collaborative datasets are allowing scientists to move beyond isolated findings and begin identifying broader patterns across diverse patient populations.
Throughout the discussion, Dr. Humphrey highlights the importance of global collaboration between researchers, clinicians, and the ALS community. He shares how post-mortem tissue analysis, genomic sequencing, and AI-driven approaches are being used together to better understand disease origins, progression, and potential therapeutic targets.
In this talk, we cover:
• How large-scale patient datasets are advancing ALS research
• The role of genetics and molecular pathways in disease development
• Why collaboration across institutions and countries is critical
• How AI and computational tools are accelerating discovery
• The challenges of working with complex, real-world data
• Emerging insights into ALS and related neurodegenerative diseases
This conversation underscores the growing role of data-driven science in ALS research. By combining patient experience with cutting-edge technology, researchers are building a more complete picture of the disease and opening new pathways toward meaningful treatments.
📲 Download the EverythingALS App
• Google Play: bit.ly/4nXqIYy
• App Store: bit.ly/42tPBmh
Follow EverythingALS:
► Website: everythingals.org
► X: https://x.com/everything_als
► LinkedIn: linkedin.com/everythingals
► Facebook: facebook.com/EverythingALS
► Subscribe for more Expert Talks: youtube.com/c/everythingals
#ExpertTalk #EverythingALS #ALSResearch #ALSCommunity #NeurodegenerativeDisease #ALSScience #ALSData #BigData #ALSAdvocacy #ALSUpdates #ALSExperts #CollaborativeScience
🔔 If you are passionate about advancing ALS research and understanding, like, subscribe, and turn on notifications.
Sharing this episode helps expand awareness and keeps important scientific conversations moving forward.







![#ExpertTalk: Targeting an Endogenous Retrovirus as a Therapeutic Approach to ALS
Welcome to another enlightening #experttalk by the EverythingALS, where we delve into cutting-edge research and innovative approaches to combating #ALS (Amyotrophic Lateral Sclerosis).
This discussion dives into the science behind endogenous retroviruses (ERVs), their role in neurodegenerative diseases, and how understanding them could pave the way for innovative treatments for ALS.
🕒 Timestamps
0:00 – Introduction
Meet the speakers and an overview of the session.
3:45 – Understanding Endogenous Retroviruses
What are ERVs, and why are they significant in neurodegenerative diseases?
10:20 – The Role of ERVs in ALS Pathology
How ERVs influence ALS development and progression.
20:15 – Innovative Therapeutic Strategies
Exploring cutting-edge research and treatment possibilities targeting ERVs.
30:50 – Q&A with the Experts
Addressing audience questions and discussing the future of ALS therapies.
40:25 – Closing Remarks
Final insights and takeaways from the session.
👩🔬 About EverythingALS:
EverythingALS is a patient-focused nonprofit organization dedicated to accelerating the discovery of treatments and a cure for ALS through collaboration, innovation, and empowering patients and researchers.
📩 Stay Connected:
Subscribe to our channel and turn on notifications to stay updated on the latest expert talks and research breakthroughs in ALS.
💡 Don’t forget to:
✅ Like this video if you found it helpful!
✅ Subscribe to our channel for more expert talks and updates: [EverythingALS YouTube Channel].
✅ Share this video to spread awareness and support ALS research.
📌 For more resources and to participate in EverythingALS initiatives, visit: everythingals.org
#ALS #EndogenousRetrovirus #ALSResearch #TherapeuticApproach #EverythingALS #Neurodegeneration #ExpertTalk: Targeting an Endogenous Retrovirus as a Therapeutic Approach to ALS](https://i.ytimg.com/vi/5VDgqCW8eOw/mqdefault.jpg)


